Dr. Lungu is Chief, Parkinson’s Clinic at the National Institute of Health (NIH). He also directs the NIH Botulinum Toxin Clinic. He is a board-certified neurologist, specializing in movement disorders, and has additional training in research methodology, clinical trial design, deep brain stimulation mechanisms, and management and neurotoxin therapy. Dr. Lungu established the first NIH Deep Brain Stimulation (DBS) program, and conducts collaborative research in several areas related to movement disorders. He leads research programs for, among others, imaging biomarkers in Parkinson’s disease, objective diagnostic and assessment measures, and therapeutic clinical trials. Dr. Lungu co-directs the NIH Movement Disorders fellowship, and every year delivers several invited lectures to the Parkinson’s community. He is the principal investigator on research projects involving multimodal diagnostic studies, novel applications of DBS therapy and clinical trials of experimental agents.
National Institute of Health
NIH BLDG. 10, Rm. 7D37, MSC 1428, 10 Center Dr.
Bethesda MD 20892